CICALA, Giuseppe
 Distribuzione geografica
Continente #
EU - Europa 1.646
NA - Nord America 1.247
AS - Asia 902
SA - Sud America 251
AF - Africa 34
OC - Oceania 7
Totale 4.087
Nazione #
US - Stati Uniti d'America 1.198
RU - Federazione Russa 902
SG - Singapore 365
BR - Brasile 201
CN - Cina 195
IT - Italia 138
IE - Irlanda 133
HK - Hong Kong 106
SE - Svezia 104
DE - Germania 65
IN - India 64
VN - Vietnam 63
PL - Polonia 49
FR - Francia 40
CH - Svizzera 39
EE - Estonia 36
GB - Regno Unito 33
CA - Canada 29
FI - Finlandia 27
NL - Olanda 18
BD - Bangladesh 16
MX - Messico 16
IQ - Iraq 15
AT - Austria 11
ID - Indonesia 11
AR - Argentina 10
ES - Italia 10
CL - Cile 9
EC - Ecuador 9
TR - Turchia 8
BE - Belgio 7
CI - Costa d'Avorio 7
CO - Colombia 7
VE - Venezuela 7
ZA - Sudafrica 7
JP - Giappone 6
TW - Taiwan 6
AU - Australia 5
LT - Lituania 5
MA - Marocco 5
PK - Pakistan 5
TH - Thailandia 5
UA - Ucraina 5
CZ - Repubblica Ceca 4
PH - Filippine 4
UY - Uruguay 4
UZ - Uzbekistan 4
BG - Bulgaria 3
CY - Cipro 3
EG - Egitto 3
IL - Israele 3
KZ - Kazakistan 3
LB - Libano 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
BO - Bolivia 2
DK - Danimarca 2
DZ - Algeria 2
GE - Georgia 2
JO - Giordania 2
KE - Kenya 2
LV - Lettonia 2
NO - Norvegia 2
NP - Nepal 2
OM - Oman 2
PY - Paraguay 2
RS - Serbia 2
SN - Senegal 2
TN - Tunisia 2
AZ - Azerbaigian 1
BN - Brunei Darussalam 1
BS - Bahamas 1
CD - Congo 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
GR - Grecia 1
HU - Ungheria 1
IS - Islanda 1
JM - Giamaica 1
KR - Corea 1
LK - Sri Lanka 1
LY - Libia 1
MK - Macedonia 1
NG - Nigeria 1
PS - Palestinian Territory 1
PT - Portogallo 1
PW - Palau 1
RO - Romania 1
SA - Arabia Saudita 1
SI - Slovenia 1
SY - Repubblica araba siriana 1
TG - Togo 1
TO - Tonga 1
Totale 4.087
Città #
Moscow 267
Ashburn 264
Singapore 231
Dallas 186
Chandler 141
Dublin 132
Hong Kong 105
Beijing 67
San Jose 67
Nyköping 55
Los Angeles 49
The Dalles 48
Warsaw 44
Messina 41
New York 38
Munich 28
Hyderabad 21
Ho Chi Minh City 20
Frankfurt am Main 19
São Paulo 19
Turku 18
Lauterbourg 16
Princeton 16
Medford 14
Redondo Beach 13
Tianjin 13
Amsterdam 12
Dearborn 12
Denver 12
Orem 12
Hanoi 11
Rome 11
Chennai 10
Guangzhou 10
Montreal 10
Santa Clara 10
Seattle 10
Vienna 10
Paternò 9
Council Bluffs 8
Des Moines 8
Jacksonville 8
Milan 8
Mumbai 8
Abidjan 7
Baghdad 7
Brussels 7
Buffalo 7
Geneva 7
Mexico City 7
Pune 7
Stockholm 7
Zurich 7
Basel 6
Boston 6
Bremen 6
Brooklyn 6
London 6
Tokyo 6
Belo Horizonte 5
Bexley 5
Brescia 5
Changsha 5
Jakarta 5
Nuremberg 5
Rio de Janeiro 5
Santiago 5
Sydney 5
Wilmington 5
Bologna 4
Brno 4
Columbus 4
Curitiba 4
Dong Ket 4
Helsinki 4
Istanbul 4
Lappeenranta 4
Montevideo 4
Ottawa 4
Poplar 4
Quito 4
Salvador 4
Toronto 4
Atlanta 3
Berlin 3
Biên Hòa 3
Brasília 3
Charlotte 3
Chiang Mai 3
City of London 3
Delhi 3
Dhaka 3
Florence 3
Guarulhos 3
Hillsboro 3
Jinan 3
Misterbianco 3
New Delhi 3
Nicosia 3
Palermo 3
Totale 2.367
Nome #
Anti-obesity drug therapy in clinical practice: Evidence of a poor prescriptive attitude 225
Characterization and preventability of adverse drug events as cause of emergency department visits: a prospective 1-year observational study 223
A comprehensive review of swallowing difficulties and dysphagia associated with antipsychotics in adults. 216
A Narrative Review on Efficacy and Safety of Proton Pump Inhibitors in Children 192
Dual orexin receptor antagonists for the treatment of insomnia disorder: Real-world safety evidence analysis and comparison with established therapeutic options 190
Adverse reactions related to proton pump inhibitors in pediatric population: an analysis of spontaneous reporting data 185
Ototoxic adverse drug reactions: A disproportionality analysis using the Italian spontaneous reporting database 183
Adverse drug reactions with oral anticoagulants: data from sicilian spontaneous reporting system database 172
Chronic Kidney Disease Management in General Practice: A Focus on Inappropriate Drugs Prescriptions 171
Effectiveness and Safety Profiles of Biological Therapies in Inflammatory Bowel Disease: Real Life Data from an Active Pharmacovigilance Project 167
Pediatric adverse reactions to antiseizure medications – An analysis of data from the Italian spontaneous reporting system (2001–2019) 159
Safety and tolerability of antipsychotic drugs in pediatric patients: data from an ongoing active pharmacovigilance study in Sicily 156
Adverse Drug Reactions with HER2-Positive Breast Cancer Treatment: An Analysis from the Italian Pharmacovigilance Database 147
Safety Profile of Biologics Used in Rheumatology: An Italian Prospective Pharmacovigilance Study 141
Biosimilars in Pediatric Inflammatory Bowel Diseases: A Systematic Review and Real Life-Based Evidence 137
Safety and Tolerability of Antipsychotic Drugs in Pediatric Patients: Data From a 1-Year Naturalistic Study 135
Clinically relevant drug interactions between newer antidepressants and oral anticoagulants 130
Clinically Relevant Interactions between Atypical Antipsychotics and Anti-Infective Agents 130
Spontaneous reporting of adverse reactions related to proton pump inhibitors 124
Cardiovascular Adverse Drug Reactions of Anti-Calcitonin Gene-Related Peptide Monoclonal Antibodies for Migraine Prevention: An Analysis from the European Spontaneous Adverse Event Reporting System 115
Safety profile of tyrosine kinase inhibitors used in non-small-cell lung cancer: An analysis from the Italian pharmacovigilance database 107
Neuropsychiatric adverse drug reactions with oral tyrosine kinase inhibitors in metastatic colorectal cancer: an analysis from the FDA Adverse Event Reporting System 103
Neuropsychiatric Adverse Drug Reactions with Tyrosine Kinase Inhibitors in Gastrointestinal Stromal Tumors: An Analysis from the European Spontaneous Adverse Event Reporting System 93
Safety of Inclisiran: A Disproportionality Analysis from the EudraVigilance Database 82
Renal Disorders with Oral Tyrosine Kinase Inhibitors in Metastatic Colorectal Cancer: An Analysis from the FDA Adverse Event Reporting System Database 74
Cardiovascular Safety Profile of BRAF and MEK Inhibitors in Melanoma: FAERS Data Through a Retrospective Disproportionality Analysis (2014–2023) 72
Neuropsychiatric Adverse Events with Monoclonal Antibodies Approved for Multiple Myeloma: An Analysis from the FDA Adverse Event Reporting System 65
Unveiling cardiovascular and respiratory toxicities with monoclonal antibodies in multiple myeloma: disproportionality analysis from the FDA Adverse Event Reporting System 64
Tolerability profile of paliperidone palmitate formulations: A pharmacovigilance analysis of the EUDRAVigilance database 55
Safety of Dual Orexin Receptor Antagonist Daridorexant: A Disproportionality Analysis of Publicly Available FAERS Data 52
Inflammation and depression: A study protocol to dissect pathogenetic mechanisms in the onset, comorbidity and treatment response 49
Two Years of Active Pharmacovigilance Surveillance and Therapeutic Reconciliation in Frail Populations: The MEAP 3.0 Study 37
null 22
Factors Associated with Parental Vaccine Hesitancy in Childhood Immunization: Insights from a Cross-Sectional Survey in Southern Italy 1
Totale 4.174
Categoria #
all - tutte 13.143
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.143


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202127 0 0 0 0 0 0 0 0 0 23 0 4
2021/2022139 5 12 1 2 4 4 9 7 1 39 6 49
2022/2023414 29 56 16 40 23 43 3 30 160 3 9 2
2023/2024171 7 16 25 12 10 34 11 8 2 25 6 15
2024/2025900 16 17 11 69 25 43 24 218 155 107 104 111
2025/20262.418 163 136 227 171 222 420 295 340 320 124 0 0
Totale 4.174